
TY  - JOUR
TI  - Abstracts of the papers presented at the 43rd Annual Meeting of The American Society of Dermatopathology
JO  - Journal of Cutaneous Pathology
VL  - 34
IS  - 1
SN  - 0303-6987
UR  - https://doi.org/10.1111/j.1600-0560.2006.00691.x
DO  - doi:10.1111/j.1600-0560.2006.00691.x
SP  - 79
EP  - 138
PY  - 2007
ER  - 

TY  - JOUR
TI  - Posters
JO  - Diabetic Medicine
VL  - 25
IS  - s1
SN  - 0742-3071
UR  - https://doi.org/10.1111/j.1464-5491.2008.02388.x
DO  - doi:10.1111/j.1464-5491.2008.02388.x
SP  - 34
EP  - 162
PY  - 2008
ER  - 

TY  - JOUR
TI  - 2017 Annual Meeting of the American Society for Bone and Mineral Research, Colorado Convention Center, Denver, CO, USA — September 8–11, 2017
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 32
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.3363
DO  - doi:10.1002/jbmr.3363
SP  - S1
EP  - S432
PY  - 2017
ER  - 

TY  - JOUR
TI  - ASGBI abstracts 2010
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 97
IS  - S2
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.7050
DO  - doi:10.1002/bjs.7050
SP  - 1
EP  - 75
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Acta Anaesthesiologica Scandinavica
JA  - Acta Anaesthesiol. Scand.
VL  - 59
IS  - S121
SN  - 0001-5172
UR  - https://doi.org/10.1111/aas.12556
DO  - doi:10.1111/aas.12556
SP  - 1
EP  - 60
PY  - 2015
ER  - 

TY  - JOUR
TI  - JUA UAA International Oral
JO  - International Journal of Urology
JA  - Int. J. Urol.
VL  - 25
IS  - S1
SN  - 0919-8172
UR  - https://doi.org/10.1111/iju.13750
DO  - doi:10.1111/iju.13750
SP  - 197
EP  - 244
PY  - 2018
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Internal Medicine Journal
VL  - 40
IS  - s1
SN  - 1444-0903
UR  - https://doi.org/10.1111/j.1445-5994.2010.02187.x
DO  - doi:10.1111/j.1445-5994.2010.02187.x
SP  - 66
EP  - 185
PY  - 2010
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Transplant International
JA  - Transpl Int
VL  - 27
IS  - s3
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.12422
DO  - doi:10.1111/tri.12422
SP  - 26
EP  - 52
PY  - 2014
ER  - 

TY  - JOUR
AU  - MacEwan, David J
TI  - Emerging therapeutic aspects in oncology
JO  - British Journal of Pharmacology
JA  - Br J Pharmacol
VL  - 169
IS  - 8
SN  - 0007-1188
UR  - https://doi.org/10.1111/bph.12304
DO  - doi:10.1111/bph.12304
SP  - 1647
EP  - 1651
KW  - chemotherapy
KW  - TKI
KW  - biologics
KW  - tumor
KW  - drug resistance
PY  - 2013
AB  - Cancer remains a peculiarly stubborn disease to treat. Some forms of cancer have seen tremendous advances in the effectiveness of their treatments, whereas other forms have remained resistant to pharmacological control. This lack of hope for success is in part due to the types of drugs that are used in the clinic, and the targeted biological system being based purely on cellular growth rates. However, recent drugs designed to affect specific signalling pathways or proteins have been showing much success. Thanks to the ingenuity of pharmacologists in understanding and targeting these processes, there have been real improvements in treatment. Here we are presented with some of the research into such critical systems that have to be understood, so that they can be conquered. We will also look at the challenges facing cancer pharmacologists and what the field may present to us all in the future. Linked Articles This article is part of a themed section on Emerging Therapeutic Aspects in Oncology. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2013.169.issue-8
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Asia-Pacific Journal of Clinical Oncology
JA  - Asia‐Pac J Clin Oncol
VL  - 10
IS  - S8
SN  - 1743-7555
UR  - https://doi.org/10.1111/ajco.12304
DO  - doi:10.1111/ajco.12304
SP  - 77
EP  - 124
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Presentation
JO  - International Journal of Stroke
JA  - Int J Stroke
VL  - 10
IS  - S2
SN  - 1747-4930
UR  - https://doi.org/10.1111/ijs.12479
DO  - doi:10.1111/ijs.12479
SP  - 77
EP  - 438
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Asia-Pacific Journal of Clinical Oncology
JA  - Asia‐Pac J Clin Oncol
VL  - 10
IS  - S8
SN  - 1743-7555
UR  - https://doi.org/10.1111/ajco.12305
DO  - doi:10.1111/ajco.12305
SP  - 126
EP  - 209
PY  - 2014
ER  - 

TY  - JOUR
TI  - 2016 Annual Meeting of the American Society for Bone and Mineral Research Atlanta, GA September 16–19, 2016
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 31
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.3107
DO  - doi:10.1002/jbmr.3107
SP  - S1
EP  - S411
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Wound Repair and Regeneration
JA  - Wound Repair Regen
VL  - 20
IS  - 5
SN  - 1067-1927
UR  - https://doi.org/10.1111/j.1524-475X.2012.00835.x
DO  - doi:10.1111/j.1524-475X.2012.00835.x
SP  - A53
EP  - A78
PY  - 2012
ER  - 

TY  - JOUR
TI  - 2014 Annual Meeting of the American Society for Bone and Mineral Research Houston, TX September 12–15, 2014
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 29
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.2476
DO  - doi:10.1002/jbmr.2476
SP  - S1
EP  - S1
PY  - 2014
AB  - ABSTRACT Searchable abstracts may be found at http://www.asbmr.org/education/abstracts
ER  - 

TY  - JOUR
TI  - IHPBA Posters
JO  - HPB
VL  - 3
IS  - 1
SN  - 1365-182X
UR  - https://doi.org/10.1080/136518201753173755
DO  - doi:10.1080/136518201753173755
SP  - 121
EP  - 151
PY  - 2001
ER  - 

AU  - Pender, Alexandra
AU  - Moorcraft, Sing Yu
AU  - Lee, Daniel L.Y.
C7  - pp. 53-184
TI  - Side effects and complications of cancer and its treatment
SN  - 9781118673829
UR  - https://doi.org/10.1002/9781118673768.ch3
DO  - doi:10.1002/9781118673768.ch3
SP  - 53-184
KW  - Side effects
KW  - complications
KW  - toxicity management
KW  - chemotherapy toxicity
KW  - targeted drug toxicity
PY  - 2001
AB  - Summary Oncology treatments can cause significant toxicities, which may be life-threatening, significantly impact on patients' quality of life or necessitate changes to their treatment. This chapter provides guidance on the most common side effects of treatment, including diarrhoea, vomiting, rashes, myelosuppression, neuropathy and mucositis. Some toxicities occur acutely, whereas others (e.g. osteoporosis, sexual dysfunction and infertility) are longer-term complications of treatment. In addition, the underlying cancer itself can lead to a number of potential complications (e.g. bowel obstruction, renal failure and biliary obstruction) which may result in emergency hospital admission. Patients require careful assessment and management, particularly as in some cases it can be difficult to determine the underlying cause. For example, fatigue, anorexia, breathlessness, confusion and thromboembolism may be caused by both cancer and its treatment.
ER  - 

TY  - JOUR
TI  - 2013 Annual Meeting of the American Society for Bone and Mineral Research Baltimore, MD October 4–7, 2013
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 28
IS  - S1
SN  - 9781118673829
UR  - https://doi.org/10.1002/jbmr.2201
DO  - doi:10.1002/jbmr.2201
SP  - S1
EP  - S1
PY  - 2013
AB  - ABSTRACT Searchable abstracts may be found at http://www.asbmr.org/education/abstracts
ER  - 

TY  - JOUR
TI  - 2011 ACCP Annual Meeting
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 31
IS  - 10
SN  - 9781118673829
UR  - https://doi.org/10.1592/phco.31.10.311e
DO  - doi:10.1592/phco.31.10.311e
SP  - 311e
EP  - 453e
PY  - 2011
ER  - 

TY  - JOUR
TI  - Swiss Society of Surgery
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 101
IS  - s5
SN  - 9781118673829
UR  - https://doi.org/10.1002/bjs.9542
DO  - doi:10.1002/bjs.9542
SP  - 1
EP  - 25
PY  - 2014
ER  - 
